United States · Series C startup
5 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$225Mraised across 5 rounds since 2008, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
RA Capital Management
Domain Associates
SR One
Omega Funds
Abingworth
Skyline Ventures
Deerfield PartnersReported by finsmes.comSEC filing: $60M sold, first sale Jul 2013
Reported by masshightech.comSEC filing: $29M sold, first sale Aug 2010
No investor was named in the report.
From a historical funding recordSEC filing: $25M sold, first sale Aug 2010
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
SR OneAbingworthOxford Bioscience PartnersSkyline VenturesRA Capital ManagementDomain AssociatesOmega FundsHealthCare VenturesBrookside CapitalDeerfield PartnersMissing a round, or an investor who was in one? Tell us.
Dicerna Pharmaceuticals's investors include SR One, Abingworth, Oxford Bioscience Partners, Skyline Ventures and RA Capital Management, and 6 more on record.
Dicerna Pharmaceuticals has raised $225M across 5 rounds since 2008.
Dicerna Pharmaceuticals's most recent round was a Series C of $60M in Jul 2013.
Dicerna Pharmaceuticals's largest round on record is $124M (Venture), in Jan 2010.
Dicerna Pharmaceuticals's first round on record, in Jul 2008, was backed by Abingworth, Oxford Bioscience Partners and Skyline Ventures.
Dicerna Pharmaceuticals's latest named round is a Series C, in Jul 2013.
Dicerna Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·